Tag Archives: Conditions and Diseases

Alzheimer’s Test Offers Early Diagnosis

By George Koroneos | Published: August 11, 2010
Image via Wikipedia A research team in Belgium discovered a new test that has proven successful at identifying patients that are developing Alzheimer’s disease, according to a report published in the Archives of Neurology on Tuesday. The study took spinal fluid from patients with varying levels of cognitive memory and looked for a specific protein signature or [...]
Posted in R&D, Technology | Also tagged , , , , , , | Leave a comment

Unbranded Pharma Sites Gain Traction

By George Koroneos | Published: May 11, 2010
Image by alles-schlumpf via Flickr The popularity of unbranded pharma Web sites amongst consumers appears to be on an up tick, according to new data released by Manhattan Research this week. The report, “Unbranded Web sites: Brand Reach throughout the Patient Life Cycle” looked at how many consumers actively use unbranded pharma sites and to what degree [...]
Posted in Marketing | Also tagged , , , , , , | Leave a comment

Merck Shows Off Bevy of New Drugs

By George Koroneos | Published: May 6, 2010
Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for launch within [...]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment

FDA to Review Prostate Cancer Meds

By George Koroneos | Published: May 4, 2010
Image via Wikipedia FDA, on Monday, announced that it was reviewing whether a certain class of prostate cancer drugs could lead to diabetes, stroke, death, or heart problems. The drugs in question are gonadotropin-Releasing Hormone (GnRH) agonists, marketed under a number of monikers, including Vantas and Lupron. These treatments are used to slow the growth of prostate [...]
Posted in FDA, Safety | Also tagged , , , , , , | Leave a comment

Dendreon Picks Bishop as COO

By George Koroneos | Published: December 14, 2009
Congratulations are in order for Hans Bishop, one of our 2009 emerging leaders. Dendreon just announced that it appointed Bishop chief operating officer in charge of the pending launch of the prostate cancer treatment Provenge. “Hans’ extensive and successful global commercial experience will add tremendous value to Dendreon’s already strong executive team as we prepare for [...]
Posted in People | Also tagged , , , , , , , | Leave a comment